Long-term outcome and quality of life in adult patients after the Fontan operation

https://doi.org/10.1016/j.amjcard.2004.01.041Get rights and content

Abstract

The first successful Fontan operation was performed in 1971, and this first cohort of Fontan patients is reaching adulthood with unclear outcome of this palliative procedure. We studied the mortality, morbidity, and quality of life in our adult Fontan patients. We examined all patients (n = 36) who underwent a Fontan procedure and were being seen in an adult outpatient clinic by using electrocardiography, exercise testing, and echocardiography. Quality of life was assessed by the Short Form 36 questionnaire. The mean follow-up period was 15 years (range 0 to 23). Of the initial 36 patients, 10 died (28%) at a mean of 10 years (range 0 to 21) after the Fontan operation and 1 patient underwent cardiac transplantation. Reoperations were performed in 21 patients (58%), and the most common reason was revision of the Fontan connection. Sustained supraventricular tachycardia was observed in 20 patients (56%) with an increased incidence of arrhythmias with longer follow-up. Thromboembolic events were detected in 9 patients (25%), 5 of whom had adequate anticoagulant levels at the time of event. The thromboembolic event was fatal for 3 patients. A total of 195 hospital admissions (mean 3.8 ± 2.7, range 1 to 13) was recorded. Quality-of-life assessment showed physical functioning, mental health, and general health perception to be significantly lower for Fontan patients than for the normal Dutch population. Thus, we found high mortality and very high morbidity in adult patients after the Fontan operation. In particular, reoperations, arrhythmias, and thromboembolic events compromised quality of life.

Section snippets

Patients

All adult patients who underwent a Fontan procedure and regularly attended the outpatient clinic of the Thoraxcenter at the Erasmus Medical Center were included in this study. In 1978, the first Fontan operation was performed in our institute. We studied the long-term follow-up from Fontan operation until last follow-up or death. In 2002, a cross-sectional study of surviving patients was undertaken. All medical and surgical records of the patients were reviewed for reoperations, arrhythmias,

Patients

Thirty-six adult patients with a Fontan procedure were seen in the outpatient clinic and included in the study. There were 18 men (50%). Mean age at the time of Fontan operation was 12 years (range 2 to 34). Twenty-nine patients were operated in childhood and reached adulthood, and 7 patients underwent the Fontan operation at an adult age. The primary cardiac malformation was tricuspid atresia in 21 patients (58%), double-inlet left ventricle in 9 patients (25%), and other complex congenital

Discussion

This study showed a surprisingly high mortality rate in young adults and a high morbidity rate after the Fontan operation. Arrhythmias, reoperations, and thromboembolic events often occurred, and all patients had ≥1 hospital admission during follow-up.

A possible risk factor for late mortality is surgery at older age.13, 14 In our patients who underwent the Fontan operation during adulthood, the mortality rate was as high as 57%. Three of our patients died suddenly after Fontan operation,

References (22)

  • J Weipert et al.

    Exercise capacity and mid-term survival in patients with tricuspid atresia and complex congenital cardiac malformations after modified Fontan-operation

    Eur J Cardiothorac Surg

    (1997)
  • Cited by (145)

    • Pathophysiology of thrombosis and anticoagulation post Fontan surgery

      2018, Thrombosis Research
      Citation Excerpt :

      Previous reports have ascertained that the total resolution of thrombosis occurs in only 48% of cases [85]. Moreover, thromboembolic events are associated with 25% mortality in pediatric patients [67,85] and 38% in adult patients [86], despite aggressive treatment of thrombi. Other outcomes of thrombosis include pulmonary embolism (which may lead to stroke or Fontan failure); collateral development (which may complicate future chest surgery); post-phlebitic syndrome; and thrombosis reoccurrence [87].

    • Maternal Congenital Heart Disease in Pregnancy

      2018, Obstetrics and Gynecology Clinics of North America
    View all citing articles on Scopus
    View full text